コンパニオンアニマル薬の世界市場:産業分析および機会分析

◆英語タイトル:Companion Animal Drugs Market - Global Industry Analysis and Opportunity Assessment, 2019-2029
◆商品コード:FMI20JA083
◆発行会社(リサーチ会社):Future Market Insights
◆発行日:2019年10月9日
◆ページ数:167
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Individual Price(1名様閲覧用)USD5,000 ⇒換算¥570,000見積依頼/購入/質問フォーム
Corporate Price(同一法人内共有可)USD7,500 ⇒換算¥855,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はFuture Market Insights社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Future Market Insights社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本調査はコンパニオンアニマル薬について、エグゼクティブサマリー、市場概要、市場動向、市場状況、バリュー分析、製品別(抗生物質、抗炎症、寄生虫駆除剤、ハートワーム製品、行動プロダクト)分析、流通経路別(獣医病院、獣医クリニック、薬局とドラッグストア)分析、産業別(エネルギー、BFSI、政府、製造業、小売)分析、地域別分析、競合分析、調査手法に区分して掲載しています。
・エグゼクティブサマリー
・市場概要
・市場動向
・市場状況
・バリュー分析
・コンパニオンアニマル薬の世界市場:製品別(抗生物質、抗炎症、寄生虫駆除剤、ハートワーム製品、行動プロダクト)
・コンパニオンアニマル薬の世界市場:流通経路別(獣医病院、獣医クリニック、薬局とドラッグストア)
・コンパニオンアニマル薬の世界市場:産業別(エネルギー、BFSI、政府、製造業、小売)
・コンパニオンアニマル薬の世界市場:地域別
・競合分析
・調査手法
【レポートの概要】

A recent market study published by Future Market Insights on the companion animal drugs market includes global industry analysis 2014-2018 & opportunity assessment 2019-2029, and delivers a comprehensive assessment of the most important market dynamics. After conducting a thorough research on the historical as well as current growth parameters of the companion animal drugs market, the growth prospects of the market are obtained with maximum precision.

Chapter 01 – Executive Summary

The report initiates with the executive summary of the companion animal drugs market, which includes a summary of key findings and statistics of the market. It also includes drivers and trends pertaining to the companion animal drugs market.

Chapter 02 – Market Overview

Readers can find the definition and a detailed segmentation of the companion animal drugs market in this chapter, which will help them understand the basic information about the companion animal drugs market. Along with this, comprehensive information pertaining to companion animal drugs and their properties are provided in this section. This section also highlights the inclusions and exclusions, which helps the reader understand the scope of the companion animal drugs market report.

Chapter 03 – Market Dynamics

This section gives information about drivers, and restraints of the companion animal drugs market. This section also includes various opportunities and key trends of the companion animal drugs market.

Chapter 04 – Market Context

This section gives information about upcoming pipeline products, PEST analysis, Porter’s Five Forces Model, and regulatory scenario of the companion animal drugs market.

Chapter 05 – Global Companion Animal Drugs Market Demand Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section explains the global market value analysis and forecast for the companion animal drugs market in the forecast periods of 2019-2029. This chapter includes a detailed analysis of the historical companion animal drugs market, along with an opportunity analysis of the future. Readers can also find the absolute $ opportunity for the current year (2019), and an incremental $ opportunity for the forecast period (2019–2029).

Chapter 06 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Product Type

Based on the product type, the companion animal drugs market is segmented into antibiotics, anti-inflammatory, parasiticides, heart worm products, behavioral products, nutritional products, skin care products and vaccines. In this chapter, readers can find information about the key trends and developments in the companion animal drugs market and market attractiveness analysis based on the type.

Chapter 07 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Distribution Channel

This chapter provides details about the companion animal drugs market based on the distribution channel, and has been classified into veterinary hospitals, veterinary clinics and pharmacies and drug stores. In this chapter, readers can understand the market attractive analysis based on the distribution channel.

Chapter 08 – Global Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029, by Region

This chapter explains how the companion animal drugs market will grow across various geographic regions such as North America, Latin America, Western Europe, Eastern Europe, Asia Pacific excluding Japan, Japan, and Middle East & Africa (MEA).

Chapter 09 – North America Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter includes a detailed analysis of the growth of the North America companion animal drugs market, along with a country-wise assessment that includes the U.S. and Canada. Readers can also find the regional trends, and market growth based on the product type, distribution channel, and countries in North America.

Chapter 10 – Latin America Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides the growth scenario of the companion animal drugs market in Latin American countries such as Brazil, Mexico, Argentina, and the Rest of Latin America. Along with this, assessment of the market across target segments has been provided.

Chapter 11 – Western Europe Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the companion animal drugs market based on its end users in several countries such as the U.K., France, Germany, Spain, Italy, Nordics, Benelux and the Rest of Western Europe are included in this chapter.

Chapter 12 – Eastern Europe Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

Important growth prospects of the companion animal drugs market based on its end users in several countries such as the Russia, Poland and the Rest of Eastern Europe are included in this chapter.

Chapter 13 – Asia Pacific excluding Japan (APEJ) Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

In this chapter, China, India, Australia and New Zealand, ASEAN and Rest of Asia Pacific countries are the prominent countries in the Asia Pacific excluding Japan region that are the prime subjects of assessment to obtain the growth prospects of the APEJ companion animal drugs market. Readers can find detailed information about the growth parameters of the APEJ companion animal drugs market during the forecast period of 2019-2029.

Chapter 14 – Japan Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This section highlights the growth prospects of the companion animal drugs market for Japan, during the forecast period of 2019-2029

Chapter 15 – MEA Companion Animal Drugs Market Analysis 2014-2018 & Opportunity Assessment 2019-2029

This chapter provides information about how the companion animal drugs market will grow in major countries in the MEA region such as GCC Countries, South Africa, and the Rest of MEA, during the forecast period of 2019-2029.

Chapter 16 – Competition Analysis

In this chapter, readers can find a comprehensive list of all the prominent stakeholders in the companion animal drugs market, along with a detailed information about each company, which includes company overview, revenue shares, strategic overview, and recent company developments. Some of the market players featured in the report are Elanco (Eli Lilly), Zoetis, Inc., Merck & Co., Inc, Merial (Boehringer Ingelheim), Sanofi, Bayer AH, Vibrac SA, and Ceva Sante.

Chapter 17 – Assumptions and Acronyms

This chapter includes a list of acronyms and assumptions that provides a base to the information and statistics included in the companion animal drugs market report.

Chapter 18 – Research Methodology

This chapter help readers understand the research methodology followed to obtain various conclusions as well as important qualitative and quantitative information about the companion animal drugs market.

【レポートの目次】

1. Executive Summary

1.1. Global Market Outlook

1.2. Analysis and Recommendations

2. Market Overview

2.1. Market Coverage / Taxonomy

2.2. Market Definition / Scope / Limitations

3. Market Dynamics

3.1. Macro-Economic Factors

3.2. Drivers

3.2.1. Supply Side Drivers

3.2.2. Demand Side Drivers

3.3. Restraints

3.4. Opportunities

3.5. Trends

4. Market Context

4.1. Market Overview

4.2. Pipeline Products

4.3. PEST Analysis

4.4. Porter’s Five Forces Model

4.5. Regulatory Scenario

4.6. U.S. Animal Healthcare Spending

5. Global Companion Animal Drugs Market Value Analysis 2014-2018 and Forecast, 2019-2029

5.1. Historical Market Value (US$ Mn) Analysis, 2014-2018

5.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029

5.2.1. Y-o-Y Growth Trend Analysis

5.2.2. Absolute $ Opportunity Analysis

6. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Product Type

6.1. Introduction / Key Findings

6.2. Historical Market Size (US$ Mn) Analysis By Product Type, 2014-2018

6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Product Type, 2019 – 2029

6.3.1. Antibiotics

6.3.2. Anti-inflammatory

6.3.3. Parasiticides

6.3.4. Heart Worm Products

6.3.5. Behavioral Products

6.3.6. Nutritional Products

6.3.7. Skin Care Products

6.3.8. Vaccines

6.4. Market Attractiveness Analysis By Product Type

7. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel

7.1. Introduction / Key Findings

7.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018

7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 – 2029

7.3.1. Veterinary Hospitals

7.3.2. Veterinary Clinics

7.3.3. Pharmacies and Drug Stores

7.4. Market Attractiveness Analysis By Distribution Channel

8. Global Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029, by Region

8.1. Introduction

8.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018

8.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 – 2029

8.3.1. North America

8.3.2. Latin America

8.3.3. Western Europe

8.3.4. Eastern Europe

8.3.5. Asia-Pacific Excluding Japan

8.3.6. Japan

8.3.7. Middle East & Africa

8.4. Market Attractiveness Analysis By Region

9. North America Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

9.1. Introduction

9.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

9.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

9.3.1. By Country

9.3.1.1. U.S.

9.3.1.2. Canada

9.3.2. By Product Type

9.3.3. By Distribution Channel

9.4. Market Attractiveness Analysis

9.5. Regional Trends

9.6. Key Impact Analysis

10. Latin America Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

10.1. Introduction

10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

10.3.1. By Country

10.3.1.1. Brazil

10.3.1.2. Mexico

10.3.1.3. Argentina

10.3.1.4. Rest of Latin America

10.3.2. By Product Type

10.3.3. By Distribution Channel

10.4. Market Attractiveness Analysis

10.5. Regional Trends

10.6. Key Impact Analysis

11. Western Europe Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

11.1. Introduction

11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

11.3.1. By Country

11.3.1.1. U.K.

11.3.1.2. France

11.3.1.3. Germany

11.3.1.4. Spain

11.3.1.5. Italy

11.3.1.6. Nordics

11.3.1.7. Benelux

11.3.1.8. Rest of Western Europe

11.3.2. By Product Type

11.3.3. By Distribution Channel

11.4. Market Attractiveness Analysis

11.5. Regional Trends

11.6. Key Impact Analysis

12. Eastern Europe Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

12.1. Introduction

12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

12.3.1. By Country

12.3.1.1. Russia

12.3.1.2. Poland

12.3.1.3. Rest of Eastern Europe

12.3.2. By Product Type

12.3.3. By Distribution Channel

12.4. Market Attractiveness Analysis

12.5. Regional Trends

12.6. Key Impact Analysis

13. Asia-Pacific Excluding Japan (APEJ) Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

13.1. Introduction

13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

13.3.1. By Country

13.3.1.1. China

13.3.1.2. India

13.3.1.3. Australia and NZ

13.3.1.4. ASEAN

13.3.1.5. Rest of Asia Pacific

13.3.2. By Product Type

13.3.3. By Distribution Channel

13.4. Market Attractiveness Analysis

13.5. Regional Trends

13.6. Key Impact Analysis

14. Middle East and Africa Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

14.1. Introduction

14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

14.3.1. By Country

14.3.1.1. GCC Countries

14.3.1.2. South Africa

14.3.1.3. Rest of MEA

14.3.2. By Product Type

14.3.3. By Distribution Channel

14.4. Market Attractiveness Analysis

14.5. Regional Trends

14.6. Key Impact Analysis

15. Japan Companion Animal Drugs Market Analysis 2014-2018 and Forecast 2019-2029

15.1. Introduction

15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018

15.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019-2029

15.3.1. By Product Type

15.3.2. By Distribution Channel

15.4. Market Attractiveness Analysis

15.5. Regional Trends

15.6. Key Impact Analysis

16. Competition Analysis

16.1. Competition Dashboard

16.2. Competition Deep Dive

16.2.1. Zoetis, Inc.

16.2.1.1. Company Overview

16.2.1.2. Segment Overview

16.2.1.3. ProductOfferings

16.2.1.4. Financial Analysis

16.2.1.5. Key Developments

16.2.1.6. Strategy Overview

16.2.2. Merck & Co, Ltd.

16.2.2.1. Company Overview

16.2.2.2. Segment Overview

16.2.2.3. ProductOfferings

16.2.2.4. Financial Analysis

16.2.2.5. Key Developments

16.2.2.6. Strategy Overview

16.2.3. Bayer AG

16.2.3.1. Company Overview

16.2.3.2. Segment Overview

16.2.3.3. ProductOfferings

16.2.3.4. Financial Analysis

16.2.3.5. Key Developments

16.2.3.6. Strategy Overview

16.2.4. Elanco

16.2.4.1. Company Overview

16.2.4.2. Segment Overview

16.2.4.3. ProductOfferings

16.2.4.4. Financial Analysis

16.2.4.5. Key Developments

16.2.4.6. Strategy Overview

16.2.5. Boehringer Ingelheim GmbH (Merial)

16.2.5.1. Company Overview

16.2.5.2. Segment Overview

16.2.5.3. ProductOfferings

16.2.5.4. Financial Analysis

16.2.5.5. Key Developments

16.2.5.6. Strategy Overview

16.2.6. Virbac Animal Health

16.2.6.1. Company Overview

16.2.6.2. Segment Overview

16.2.6.3. ProductOfferings

16.2.6.4. Financial Analysis

16.2.6.5. Key Developments

16.2.6.6. Strategy Overview

16.2.7. Ceva Santé Animale

16.2.7.1. Company Overview

16.2.7.2. Segment Overview

16.2.7.3. ProductOfferings

16.2.7.4. Financial Analysis

16.2.7.5. Key Developments

16.2.7.6. Strategy Overview

17. Assumptions and Acronyms Used

18. Research Methodology



【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[コンパニオンアニマル薬の世界市場:産業分析および機会分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆